Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

258

Participants

Timeline

Start Date

October 24, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

October 31, 2026

Conditions

SafetyTolerabilityEfficacy

Interventions

DRUG

Test Product HY07121

HY07121 should be administered intravenously at recommended dose.

Trial Locations (1)

RECRUITING

Cancer Hospital of Shandong First Medical University, Jinan

All Listed Sponsors

lead

Sichuan Huiyu Pharmaceutical Co., Ltd

INDUSTRY